Showing results (1-10 of 139) with videos related to
Sort By:
Pageof 14
The Journal of Biological Chemistry|February 25, 1994
Isolation and characterization of thrombin-activated human factor VIIIJ E Curtis, S L Helgerson, E T Parker, et al.The Journal of Clinical Investigation|June 1, 1994
Inhibition of human factor VIIIa by anti-A2 subunit antibodiesP Lollar, E T Parker, J E Curtis, et al.The Journal of Biological Chemistry|July 5, 1991
Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homologP Lollar, E T ParkerThe Journal of Biological Chemistry|November 25, 1992
Coagulant properties of hybrid human/porcine factor VIII moleculesP Lollar, E T Parker, P J FayJournal of Thrombosis and Haemostasis : JTH|December 3, 2017
Identification of aggregates in therapeutic formulations of recombinant full-length factor VIII products by sedimentation velocity analytical ultracentrifugationJ F Healey, E T Parker, P LollarThe Journal of Biological Chemistry|October 28, 1994
Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activatorR T Barrow, E T Parker, S Krishnaswamy, et al.Biochemistry|August 5, 1997
Subunit structure and function of porcine factor Xa-activated factor VIIIE T Parker, J Pohl, M N Blackburn, et al.Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Comparative immunogenicity of recombinant B domain-deleted porcine factor VIII and Hyate:C in hemophilia A mice presensitized to human factor VIIIE T Parker, H N Craddock, R T Barrow, et al.The Journal of Biological Chemistry|August 25, 1992
Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesiclesE J Duffy, E T Parker, V P Mutucumarana, et al.Journal of Thrombosis and Haemostasis : JTH|February 4, 2009
Non-classical anti-factor VIII C2 domain antibodies are pathogenic in a murine in vivo bleeding modelS L Meeks, J F Healey, E T Parker, et al.Pageof 14